Loading candles…
Pfizer Ltd is a subsidiary of Pfizer Inc operating primarily in India, where it manufactures, markets, trades, and exports pharmaceutical products. The company offers a range of products including pharmaceutical and healthcare products, vaccines, oncology treatments, internal medicine, and inflammation and immunology products. Pfizer Ltd distributes its products through independent distributors and utilizes both its own manufacturing facilities and independent third-party manufacturers. It operates within the pharmaceutical and healthcare industries and is recognized as the third largest multinational pharmaceutical company in India, with a presence in the country spanning over seven decades.
This page is a live market overview for PFIZER LTD (PFIZER) on the NSE. As a listed security, PFIZER LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for PFIZER before placing trades on tick2trade.
As of the latest feed, PFIZER last traded at ₹4,880.6 on NSE, down ₹19.4 (0.40%) from the previous close of ₹4,900. Today's session range is ₹4,850 – ₹4,925, against a 52-week band of ₹4,360.1 – ₹5,873.5. Traded volume today stands at 5.86K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for PFIZER in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether PFIZER is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for PFIZER LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in PFIZER. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated PFIZER option chain page linked from this overview.
| Date |
|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 28 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 12 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 9 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 12 Nov 2025 |
| Results - Q1-FY25 | This is to inform that a meeting of the Board of Directors of the Company is scheduled to beheld on Wednesday, August 13, 2025 inter alia, to consider, appro… | 13 Aug 2025 |
| Audited Results - Q4 & FY25 | This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 19, 2025 inter alia, to consider, approve an… | 19 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.